{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T07:47:40Z","timestamp":1794469660936,"version":"4.9.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To describe children hospitalized with community-acquired pneumonia complicated by effusion (cCAP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>A Canadian children\u2019s hospital.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Children without significant medical comorbidities aged\u2009&lt;\u200918 years admitted from January 2015-December 2019 to either the Paediatric Medicine or Paediatric General Surgery services with any pneumonia discharge code who were documented to have an effusion\/empyaema using ultrasound.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcome measures<\/jats:title>\n                    <jats:p>Length of stay; admission to the paediatric intensive care unit; microbiologic diagnosis; antibiotic use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There were 109 children without significant medical comorbidities hospitalized for confirmed cCAP during the study period. Their median length of stay was 9 days (Q1-Q3 6\u201311 days) and 35\/109 (32%) were admitted to the paediatric intensive care unit. Most (89\/109, 74%) underwent procedural drainage. Length of stay was not associated with effusion size but was associated with time to drainage (0.60 days longer stay per day delay in drainage, 95%CI 0.19-1.0 days). Microbiologic diagnosis was more often made via molecular testing of pleural fluids (43\/59, 73%) than via blood culture (12\/109, 11%); the main aetiologic pathogens were\n                      <jats:italic>S. pneumoniae<\/jats:italic>\n                      (40\/109, 37%),\n                      <jats:italic>S. pyogenes<\/jats:italic>\n                      (15\/109, 14%), and\n                      <jats:italic>S. aureus<\/jats:italic>\n                      (7\/109, 6%). Discharge on a narrow spectrum antibiotic (i.e. amoxicillin) was much more common when the cCAP pathogen was identified as compared to when it was not (68% vs. 24%, p\u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Children with cCAP were commonly hospitalized for prolonged periods. Prompt procedural drainage was associated with shorter hospital stays. Pleural fluid testing often facilitated microbiologic diagnosis, which itself was associated with more appropriate antibiotic therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12887-023-04004-2","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:03:17Z","timestamp":1681862597000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Children hospitalized with community-acquired pneumonia complicated by effusion: a single-centre retrospective cohort study"],"prefix":"10.1186","volume":"23","author":[{"given":"Gelila","family":"Alemayheu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire S. J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura K.","family":"Erdman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candy","family":"Rutherford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Smieja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Pernica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,19]]},"reference":[{"key":"4004_CR1","doi-asserted-by":"crossref","unstructured":"Kaiser SV, Rodean J, Coon ER, Mahant S, Gill PJ, Leyenaar JK. Common diagnoses and costs in pediatric hospitalization in the US.JAMA Pediatr2021","DOI":"10.1001\/jamapediatrics.2021.5171"},{"key":"4004_CR2","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1001\/jamapediatrics.2020.6735","volume":"175","author":"JM Pernica","year":"2021","unstructured":"Pernica JM, Harman S, Kam AJ, et al. Short-course antimicrobial therapy for pediatric community-acquired pneumonia: the SAFER randomized clinical trial. JAMA Pediatr. 2021;175:475\u201382.","journal-title":"JAMA Pediatr"},{"key":"4004_CR3","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1001\/jama.2021.17843","volume":"326","author":"JA Bielicki","year":"2021","unstructured":"Bielicki JA, Stohr W, Barratt S, et al. Effect of amoxicillin dose and treatment duration on the need for antibiotic re-treatment in children with community-acquired pneumonia: the CAP-IT randomized clinical trial. JAMA. 2021;326:1713\u201324.","journal-title":"JAMA"},{"key":"4004_CR4","doi-asserted-by":"crossref","unstructured":"Williams DJ, Creech CB, Walter EB et al. Short- vs standard-course outpatient antibiotic therapy for community-acquired pneumonia in children: The SCOUT-CAP randomized clinical trial.JAMA Pediatr2022","DOI":"10.1001\/jamapediatrics.2021.5547"},{"key":"4004_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1471-2334-8-129","volume":"8","author":"JM Langley","year":"2008","unstructured":"Langley JM, Kellner JD, Solomon N, et al. Empyema associated with community-acquired pneumonia: a pediatric investigator\u2019s collaborative network on infections in Canada (PICNIC) study. BMC Infect Dis. 2008;8:129.","journal-title":"BMC Infect Dis"},{"key":"4004_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1086\/648593","volume":"201","author":"T Pilishvili","year":"2010","unstructured":"Pilishvili T, Lexau C, Farley MM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 2010;201:32\u201341.","journal-title":"J Infect Dis"},{"key":"4004_CR7","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1086\/650573","volume":"50","author":"CG Grijalva","year":"2010","unstructured":"Grijalva CG, Nuorti JP, Zhu Y, Griffin MR. Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States. Clin Infect Dis. 2010;50:805\u201313.","journal-title":"Clin Infect Dis"},{"key":"4004_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1542\/peds.2009-0184","volume":"125","author":"ST Li","year":"2010","unstructured":"Li ST, Tancredi DJ. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine. Pediatrics. 2010;125:26\u201333.","journal-title":"Pediatrics"},{"key":"4004_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2471\/BLT.12.109231","volume":"91","author":"RE Strachan","year":"2013","unstructured":"Strachan RE, Snelling TL, Jaffe A. Increased paediatric hospitalizations for empyema in Australia after introduction of the 7-valent pneumococcal conjugate vaccine. Bull World Health Organ. 2013;91:167\u201373.","journal-title":"Bull World Health Organ"},{"key":"4004_CR10","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1097\/INF.0b013e3181df2c70","volume":"29","author":"K Ampofo","year":"2010","unstructured":"Ampofo K, Herbener A, Blaschke AJ, et al. Association of 2009 pandemic influenza A (H1N1) infection and increased hospitalization with parapneumonic empyema in children in Utah. Pediatr Infect Dis J. 2010;29:905\u20139.","journal-title":"Pediatr Infect Dis J"},{"key":"4004_CR11","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.jinf.2015.06.011","volume":"71","author":"S Saxena","year":"2015","unstructured":"Saxena S, Atchison C, Cecil E, Sharland M, Koshy E, Bottle A. Additive impact of pneumococcal conjugate vaccines on pneumonia and empyema hospital admissions in England. J Infect. 2015;71:428\u201336.","journal-title":"J Infect"},{"key":"4004_CR12","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1093\/cid\/cix115","volume":"64","author":"L Olarte","year":"2017","unstructured":"Olarte L, Barson WJ, Barson RM, et al. Pneumococcal pneumonia requiring hospitalization in US children in the 13-valent pneumococcal conjugate vaccine era. Clin Infect Dis. 2017;64:1699\u2013704.","journal-title":"Clin Infect Dis"},{"key":"4004_CR13","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.cmi.2018.10.020","volume":"25","author":"JG Liese","year":"2019","unstructured":"Liese JG, Schoen C, van der Linden M, et al. Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions\/empyema in Germany, 2010\u20132017: a nationwide surveillance study. Clin Microbiol Infect. 2019;25:857\u201364.","journal-title":"Clin Microbiol Infect"},{"key":"4004_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1155\/2014\/757963","volume":"25","author":"JM Pernica","year":"2014","unstructured":"Pernica JM, Moldovan I, Chan F, Slinger R. Real-time polymerase chain reaction for microbiological diagnosis of parapneumonic effusions in canadian children. Can J Infect Dis Med Microbiol. 2014;25:151\u20134.","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"4004_CR15","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/INF.0000000000002699","volume":"39","author":"O Megged","year":"2020","unstructured":"Megged O. Characteristics of streptococcus pyogenes versus Streptococcus pneumoniae pleural empyema and pneumonia with pleural effusion in children. Pediatr Infect Dis J. 2020;39:799\u2013802.","journal-title":"Pediatr Infect Dis J"},{"key":"4004_CR16","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1002\/ppul.25564","volume":"56","author":"K Rix-Trott","year":"2021","unstructured":"Rix-Trott K, Byrnes CA, Gilchrist CA, et al. Surveillance of pediatric parapneumonic effusion\/empyema in New Zealand. Pediatr Pulmonol. 2021;56:2949\u201357.","journal-title":"Pediatr Pulmonol"},{"key":"4004_CR17","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1093\/cid\/cir531","volume":"53","author":"JS Bradley","year":"2011","unstructured":"Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the PIDS and IDSA. Clin Infect Dis. 2011;53:e25\u201376.","journal-title":"Clin Infect Dis"},{"key":"4004_CR18","unstructured":"\u201cPaediatric complicated pneumonia. : Diagnosis and management of empyema\u201d https:\/\/cps.ca\/en\/documents\/position\/complicated-pneumonia-empyema. Last Accessed 2022 July 17"},{"key":"4004_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/INF.0b013e3182002d14","volume":"30","author":"AJ Blaschke","year":"2011","unstructured":"Blaschke AJ, Heyrend C, Byington CL, et al. Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema. Pediatr Infect Dis J. 2011;30:289\u201394.","journal-title":"Pediatr Infect Dis J"},{"key":"4004_CR20","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(20)31550-6","volume":"396","author":"FM de Benedictis","year":"2020","unstructured":"de Benedictis FM, Kerem E, Chang AB, Colin AA, Zar HJ. Bush A. Complicated pneumonia in children. Lancet. 2020;396:786\u201398.","journal-title":"Lancet"},{"key":"4004_CR21","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1016\/j.jpedsurg.2012.07.047","volume":"47","author":"S Islam","year":"2012","unstructured":"Islam S, Calkins CM, Goldin AB, et al. The diagnosis and management of empyema in children: a comprehensive review from the APSA outcomes and clinical trials committee. J Pediatr Surg. 2012;47:2101\u201310.","journal-title":"J Pediatr Surg"},{"key":"4004_CR22","volume-title":"Immunization coverage report for school pupils in Ontario: 2018-19 school year","author":"Ontario Agency for Health Protection and Promotion (Public Health Ontario)","year":"2020","unstructured":"Ontario Agency for Health Protection and Promotion (Public Health Ontario). Immunization coverage report for school pupils in Ontario: 2018-19 school year. Toronto: Queen\u2019s Printer for Ontario; 2020."},{"key":"4004_CR23","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1056\/NEJMoa1405870","volume":"372","author":"S Jain","year":"2015","unstructured":"Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372:835\u201345.","journal-title":"N Engl J Med"},{"key":"4004_CR24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1473-3099(22)00525-4","volume":"23","author":"M Bardsley","year":"2023","unstructured":"Bardsley M, Morbey RA, Hughes HE, et al. Epidemiology of respiratory Syncytial Virus in children younger than 5 years in England during the covid-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study. Lancet Infect Dis. 2023;23:56\u201366.","journal-title":"Lancet Infect Dis"},{"key":"4004_CR25","first-page":"100015","volume":"1","author":"HE Groves","year":"2021","unstructured":"Groves HE, Piche-Renaud PP, Peci A, et al. The impact of the covid-19 pandemic on influenza, respiratory syncytial virus, and other seasonal respiratory virus circulation in Canada: a population-based study. Lancet Reg Health Am. 2021;1:100015.","journal-title":"Lancet Reg Health Am"},{"key":"4004_CR26","doi-asserted-by":"publisher","first-page":"e1001776","DOI":"10.1371\/journal.pmed.1001776","volume":"12","author":"DM Weinberger","year":"2015","unstructured":"Weinberger DM, Klugman KP, Steiner CA, Simonsen L, Viboud C. Association between Respiratory Syncytial Virus activity and pneumococcal disease in infants: a time series analysis of us hospitalization data. PLoS Med. 2015;12:e1001776.","journal-title":"PLoS Med"},{"key":"4004_CR27","doi-asserted-by":"publisher","first-page":"191ra184","DOI":"10.1126\/scitranslmed.3005982","volume":"5","author":"S Shrestha","year":"2013","unstructured":"Shrestha S, Foxman B, Weinberger DM, Steiner C, Viboud C. Rohani P. identifying the interaction between influenza and pneumococcal pneumonia using incidence data. Sci Transl Med. 2013;5:191ra184.","journal-title":"Sci Transl Med"},{"key":"4004_CR28","doi-asserted-by":"publisher","first-page":"e2218959","DOI":"10.1001\/jamanetworkopen.2022.18959","volume":"5","author":"A Rybak","year":"2022","unstructured":"Rybak A, Levy C, Angoulvant F, et al. Association of nonpharmaceutical interventions during the COVID-19 pandemic with invasive pneumococcal disease, pneumococcal carriage, and respiratory viral infections among children in France. JAMA Netw Open. 2022;5:e2218959.","journal-title":"JAMA Netw Open"},{"key":"4004_CR29","doi-asserted-by":"crossref","unstructured":"Danino D, Ben-Shimol S, Van Der Beek BA et al. Decline in pneumococcal disease in young children during the COVID-19 pandemic in Israel associated with suppression of seasonal respiratory viruses, despite persistent pneumococcal carriage: A prospective cohort study.Clin Infect Dis2021","DOI":"10.1101\/2021.07.29.21261308"},{"key":"4004_CR30","doi-asserted-by":"crossref","unstructured":"Chan KF, Ma TF, Sridhar S, Lam DC, Ip MS, Ho PL. Changes in etiology and clinical outcomes of pleural empyema during the COVID-19 pandemic.Microorganisms2023;11","DOI":"10.3390\/microorganisms11020303"},{"key":"4004_CR31","doi-asserted-by":"publisher","first-page":"e2141779","DOI":"10.1001\/jamanetworkopen.2021.41779","volume":"4","author":"Z Zheng","year":"2021","unstructured":"Zheng Z, Pitzer VE, Shapiro ED, Bont LJ, Weinberger DM. Estimation of the timing and intensity of reemergence of respiratory syncytial virus following the COVID-19 pandemic in the US. JAMA Netw Open. 2021;4:e2141779.","journal-title":"JAMA Netw Open"},{"key":"4004_CR32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4103\/prcm.prcm_12_22","volume":"6","author":"S Sadani","year":"2022","unstructured":"Sadani S, Das M. Assessment of bacteriological profile and outcome of empyema thoracis of hospitalized children: a single center experience. Pediatr Respirol Crit Care Med. 2022;6:47\u201353.","journal-title":"Pediatr Respirol Crit Care Med"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-023-04004-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-023-04004-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-023-04004-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,10]],"date-time":"2023-12-10T18:32:40Z","timestamp":1702233160000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-023-04004-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4004"],"URL":"https:\/\/doi.org\/10.1186\/s12887-023-04004-2","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,19]]},"assertion":[{"value":"28 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was approved by the Hamilton Integrated Research Ethics Board (2020\u20138336). All methods were carried out in accordance with relevant guidelines and regulations. For this retrospective chart review study, the need to seek informed consent from individual patients was waived by the Hamilton Integrated Research Ethics Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JMP\u2019s institution has received grant funding from MedImmune for work unrelated to the topic under study in this manuscript. His institution also received grant funding from Merck for a pneumonia study that had not begun by the time this manuscript was submitted for publication. No other study authors had competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"181"}}